IL153476A0 - Novel heteroaryl derivatives and the use thereof as pharmaceuticals - Google Patents

Novel heteroaryl derivatives and the use thereof as pharmaceuticals

Info

Publication number
IL153476A0
IL153476A0 IL15347601A IL15347601A IL153476A0 IL 153476 A0 IL153476 A0 IL 153476A0 IL 15347601 A IL15347601 A IL 15347601A IL 15347601 A IL15347601 A IL 15347601A IL 153476 A0 IL153476 A0 IL 153476A0
Authority
IL
Israel
Prior art keywords
pharmaceuticals
heteroaryl derivatives
novel heteroaryl
novel
derivatives
Prior art date
Application number
IL15347601A
Other languages
English (en)
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of IL153476A0 publication Critical patent/IL153476A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15347601A 2000-07-21 2001-07-18 Novel heteroaryl derivatives and the use thereof as pharmaceuticals IL153476A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10035927A DE10035927A1 (de) 2000-07-21 2000-07-21 Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
PCT/EP2001/008263 WO2002008194A1 (de) 2000-07-21 2001-07-18 Acridin-derivate und deren verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
IL153476A0 true IL153476A0 (en) 2003-07-06

Family

ID=7649979

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15347601A IL153476A0 (en) 2000-07-21 2001-07-18 Novel heteroaryl derivatives and the use thereof as pharmaceuticals

Country Status (29)

Country Link
US (1) US6706722B2 (xx)
EP (1) EP1301485B1 (xx)
JP (1) JP2004504382A (xx)
KR (1) KR20030022296A (xx)
CN (1) CN1296359C (xx)
AR (1) AR033383A1 (xx)
AT (1) ATE365717T1 (xx)
AU (2) AU8967501A (xx)
BG (1) BG107507A (xx)
BR (1) BR0112591A (xx)
CA (1) CA2353360A1 (xx)
CY (1) CY1106890T1 (xx)
CZ (1) CZ2003427A3 (xx)
DE (2) DE10035927A1 (xx)
DK (1) DK1301485T3 (xx)
ES (1) ES2291349T3 (xx)
HK (1) HK1057549A1 (xx)
HU (1) HUP0303729A3 (xx)
IL (1) IL153476A0 (xx)
MX (1) MXPA02012564A (xx)
NO (1) NO324939B1 (xx)
NZ (1) NZ524155A (xx)
PL (1) PL358808A1 (xx)
PT (1) PT1301485E (xx)
RU (1) RU2267488C2 (xx)
SK (1) SK1932003A3 (xx)
UA (1) UA75085C2 (xx)
WO (1) WO2002008194A1 (xx)
ZA (1) ZA200210411B (xx)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10035928A1 (de) * 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
DE10037310A1 (de) * 2000-07-28 2002-02-07 Asta Medica Ag Neue Indolderivate und deren Verwendung als Arzneimittel
AU2003246571B2 (en) * 2002-06-29 2008-06-26 Zentaris Gmbh Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases
JP2005537258A (ja) * 2002-07-17 2005-12-08 ツェンタリス ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規アントラセン誘導体及び医薬品としてのその使用
US7125461B2 (en) * 2003-05-07 2006-10-24 L & L Products, Inc. Activatable material for sealing, baffling or reinforcing and method of forming same
FR2855825B1 (fr) * 2003-06-04 2008-08-22 Aventis Pharma Sa Produits aryl-heteroaromatiques, compositions les contenant et utilisation
AR044586A1 (es) * 2003-06-04 2005-09-21 Aventis Pharma Sa Productos aril - heteroaromaticos, composiciones que los contienen y su utilizacion
US7249415B2 (en) * 2003-06-26 2007-07-31 Zephyros, Inc. Method of forming members for sealing or baffling
DE10331500A1 (de) * 2003-07-11 2005-02-24 Zentaris Gmbh Neue Acridin-Derivate und deren Verwendung als Arzneimittel
US20070299093A1 (en) * 2005-01-27 2007-12-27 Alma Mater Studiorum-Universitá Di Bologna Organic Compounds Useful for the Treatment of Alzheimer's Disease, Their Use and Method of Preparation
AU2006209079A1 (en) * 2005-01-27 2006-08-03 Alma Mater Studiorum-Universita' Di Bologna Organic compounds useful for the treatment of Alzheimer's disease, their use and method of preparation
EP2125750B1 (en) * 2007-02-26 2014-05-21 Vitae Pharmaceuticals, Inc. Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5451611B2 (ja) * 2007-07-26 2014-03-26 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1のサイクリックインヒビター
AR069207A1 (es) * 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
JP5490014B2 (ja) 2007-12-11 2014-05-14 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1型の環状尿素阻害剤
TW200934490A (en) * 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
WO2009094169A1 (en) * 2008-01-24 2009-07-30 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5734666B2 (ja) * 2008-02-11 2015-06-17 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の1,3−オキサアゼパン−2−オン及び1,3−ジアゼパン−2−オン阻害剤
EP2254872A2 (en) * 2008-02-15 2010-12-01 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
EP2274287B1 (en) * 2008-03-18 2016-03-09 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
EP2291370B1 (en) 2008-05-01 2013-11-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2291373B1 (en) * 2008-05-01 2013-09-11 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8569292B2 (en) 2008-05-01 2013-10-29 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
JP5301563B2 (ja) 2008-05-01 2013-09-25 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状インヒビター
JP5777030B2 (ja) 2008-07-25 2015-09-09 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 11β−ヒドロキシステロイドデヒドロゲナーゼ1の阻害剤
JP5379160B2 (ja) 2008-07-25 2013-12-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状インヒビター
EP2393807B1 (en) 2009-02-04 2013-08-14 Boehringer Ingelheim International GmbH Cyclic inhibitors of 11 -hydroxysteroid dehydrogenase 1
TW201039034A (en) * 2009-04-27 2010-11-01 Chunghwa Picture Tubes Ltd Pixel structure and the method of forming the same
US20100331320A1 (en) * 2009-04-30 2010-12-30 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
MA33216B1 (fr) 2009-04-30 2012-04-02 Boehringer Ingelheim Int Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
WO2011011123A1 (en) 2009-06-11 2011-01-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
JP5749263B2 (ja) 2009-07-01 2015-07-15 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状インヒビター
JP5860042B2 (ja) 2010-06-16 2016-02-16 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 置換5、6及び7員複素環、そのような化合物を含有する医薬及びそれらの使用
JP5813106B2 (ja) 2010-06-25 2015-11-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 代謝障害の処置のための11−β−HSD1のインヒビターとしてのアザスピロヘキサノン
AU2011325286B2 (en) 2010-11-02 2015-04-16 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of metabolic disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2538388B1 (fr) 1982-12-24 1985-06-21 Pharmuka Lab Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments
US5030631A (en) * 1989-11-27 1991-07-09 Schering Corporation Tricylclic arylsulfonamides
CZ59398A3 (cs) * 1996-06-29 1998-07-15 Samjin Pharmaceutical Co., Ltd. Piperazinové deriváty a způsob jejich přípravy
US5861395A (en) 1996-09-13 1999-01-19 Schering Corporation Compounds useful for inhibition of farnesyl proteins transferase
FR2753706B1 (fr) 1996-09-20 1998-10-30 Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant
DE19743435A1 (de) 1997-10-01 1999-04-08 Merck Patent Gmbh Benzamidinderivate
EP1107758A2 (en) 1998-08-28 2001-06-20 Scios Inc. Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
AU3248600A (en) 1999-03-03 2000-09-21 Merck & Co., Inc. Inhibitors of prenyl-protein transferases

Also Published As

Publication number Publication date
CN1296359C (zh) 2007-01-24
NZ524155A (en) 2005-04-29
US6706722B2 (en) 2004-03-16
JP2004504382A (ja) 2004-02-12
BR0112591A (pt) 2003-07-22
AU2001289675B2 (en) 2005-04-07
KR20030022296A (ko) 2003-03-15
ZA200210411B (en) 2003-02-26
CZ2003427A3 (cs) 2003-06-18
AR033383A1 (es) 2003-12-17
HUP0303729A3 (en) 2009-01-28
UA75085C2 (en) 2006-03-15
DK1301485T3 (da) 2007-11-05
HUP0303729A2 (hu) 2004-03-01
CA2353360A1 (en) 2002-01-21
AU8967501A (en) 2002-02-05
HK1057549A1 (en) 2004-04-08
PL358808A1 (en) 2004-08-23
DE50112669D1 (de) 2007-08-09
NO324939B1 (no) 2008-01-07
SK1932003A3 (en) 2003-10-07
PT1301485E (pt) 2007-08-30
CY1106890T1 (el) 2012-09-26
CN1443172A (zh) 2003-09-17
EP1301485B1 (de) 2007-06-27
ES2291349T3 (es) 2008-03-01
RU2267488C2 (ru) 2006-01-10
NO20030301D0 (no) 2003-01-20
WO2002008194A8 (de) 2003-05-08
US20020132821A1 (en) 2002-09-19
EP1301485A1 (de) 2003-04-16
NO20030301L (no) 2003-03-11
DE10035927A1 (de) 2002-03-07
BG107507A (bg) 2003-09-30
ATE365717T1 (de) 2007-07-15
WO2002008194A1 (de) 2002-01-31
MXPA02012564A (es) 2003-09-22

Similar Documents

Publication Publication Date Title
AU8967501A (en) Novel heteroaryl derivatives and the use thereof as pharmaceuticals
IL153361A0 (en) Novel heteroaryl derivatives and the use thereof as pharmaceuticals
AU2001289675A1 (en) Novel Heteroaryl Derivatives and the Use Thereof as Pharmaceuticals
AU2001279757A1 (en) Novel heteroaryl derivatives and the use thereof as pharmaceuticals
AU8198901A (en) Novel heteroaryl derivatives and use thereof as medicaments
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
AU2001281989A1 (en) Novel heteroaryl derivatives and use thereof as anti-tumour agents
AU2002226486A1 (en) Novel c-glycoside derivatives and use thereof
HUP0300746A3 (en) Proline derivatives and use thereof as drugs
IL155196A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
AU2002226487A1 (en) Novel c-glycoside derivatives and use thereof
IL150449A0 (en) Aniline derivatives and pharmaceutical compositions containing the same
AP2001002250A0 (en) Pharmaceuticals
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
ZA200309513B (en) Novel heterocyclic derivatives and medicinal use thereof.
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
IL149993A0 (en) Novel heteroaryl derivatives, their preparation and use
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
SI1301485T1 (sl) Derivati akridina in njihova uporaba kot zdravila
IL160606A0 (en) C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals
IL160608A0 (en) C2-substituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals
HRP20020971A2 (en) 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-inhibitors
GB0031526D0 (en) Novel pharmaceuticals
GB0020346D0 (en) Pharmaceuticals
GB0029556D0 (en) Pharmaceuticals